Argus, Khaitan act on Ind-Swift Laboratories sale of API and CRAMS businesses to Synthimed Labs

Ind Swift Laboratories has sold its API and CRAMS businesses to Synthimed Labs for ₹1,650 crores.

Related Keywords

India ,Brazil ,Jammu ,Jammu And Kashmir ,Japan , ,Piramal Enterprises ,India Resurgence Fund ,Ind Swift Laboratories ,Resurgence Fund ,Piramal Enterprises Limited ,Argus Partners ,Synthimed Labs ,Essix Biosciences ,Active Pharmaceutical Ingredients ,Tapi ,Contract Research And Manufacturing Services ,Scrams ,Intermediates Manufacturing Business ,Indian Law Firms ,Law Firm News ,Deals ,Khaitan Amp Co ,